✦ LIBER ✦

PCN70 Cost-Effectiveness of Cetuximab and Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer (mCRC) for Patients with Kras Wild-Type Tumours in the United Kingdom

✍ Scribed by Samyshkin, Y.; Hertel, N.; Griebsch, I.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3617 POSTER Cost-Effectiveness of Cetuxi

✍ Samyshkin, Y.; Hertel, N.; Griebsch, I. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Economic analysis of bevacizumab, cetuxi

✍ Lawrence, Donna; Maschio, Michael; Leahy, Kevin J.; Yunger, Simon; Easaw, Jacob 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 466 KB

Cost-Effectiveness of Cetuximab, Cetuxim

✍ Hoyle, Martin; Peters, Jaime; Crathorne, Louise; Jones-Hughes, Tracey; Cooper, C 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

PCN19 COST EFFECTIVENESS OF CETUXIMAB IN

✍ D Garrell; I Griebsch; Y Samyshkin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PCN64 The Cost Effectiveness of Cetuxima

✍ Chaugule, S.; Hay, J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

P9 Comparison of cetuximab and bevacizum

✍ Zhang, Q.; Leung, R.; Wong, H.; Chiu, J.; Chu, K.W.; Poon, J.; Epstein, R.J.; Kw 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 185 KB